Mereo BioPharma (MREO) EBITDA (2023 - 2026)
Mereo BioPharma (MREO) reported EBITDA of -$8.5 million for Q1 2026, up 9.23% year-over-year from -$7.8 million in Q1 2025, and down 16.56% quarter-over-quarter from -$7.3 million in Q4 2025.
Mereo BioPharma (MREO) EBITDA (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of EBITDA data on file, last reported at -$8.5 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$8.5 million, up 9.23% year-over-year; the trailing twelve-month figure through Mar 2026 was -$33.0 million (up 25.35% YoY), and the FY2025 annual result was -$33.9 million, up 24.13% from the prior year.
- EBITDA declined to -$8.5 million in Q1 2026 per MREO's latest filing, from -$7.3 million in the prior quarter.
- Over five years, EBITDA peaked at -$351000.0 in Q2 2023 and troughed at -$14.8 million in Q4 2024.
- A 4-year average of -$8.6 million and a median of -$9.3 million in 2025 frame the typical range for EBITDA.
- The sharpest annual moves came in 2024 and 2025: EBITDA tumbled 3390.03% in 2024, then soared 50.89% in 2025.
- A 4-year view of EBITDA shows it stood at -$5.0 million in 2023, then sank by 195.47% to -$14.8 million in 2024, then soared by 50.89% to -$7.3 million in 2025, then retreated by 16.56% to -$8.5 million in 2026.
- Business Quant data shows MREO's EBITDA at -$8.5 million in Q1 2026, -$7.3 million in Q4 2025, and -$9.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | -8.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.47 Mn |
| Dec 31, 2025 | -7.26 Mn |
| Sep 30, 2025 | -9.29 Mn |
| Jun 30, 2025 | -7.97 Mn |
| Mar 31, 2025 | -9.33 Mn |
| Dec 31, 2024 | -14.79 Mn |
| Sep 30, 2024 | -7.83 Mn |
| Jun 30, 2024 | -12.25 Mn |
| Mar 31, 2024 | -9.75 Mn |
| Dec 31, 2023 | -5.01 Mn |
| Sep 30, 2023 | -10.11 Mn |
| Jun 30, 2023 | -351,000.00 |
| Mar 31, 2023 | -9.80 Mn |